Contact

Supporting Drug Development at Phase III

Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa

MPI Research is a full early-stage drug development CRO that partners with biopharmaceutical, biotechnology, medical device, animal health, and chemical industries to advance global healthcare. MPI Research supports all phases of the drug development pathway, ranging from target identification

Contact

Phase I Clinic Capabilities

Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa

PPD’s Phase I clinic conducts approximately 100 studies per year and has sufficient capacity to carry out multiple studies of varying design simultaneously. Research-experienced, board-certified physicians serve as principal investigators for Phase I studies. Secure and confidential drug

Contact

Phase 1 Clinical Pharmacology Study

Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa

Quotient has the experience and expertise to seamlessly deliver your studies with the highest quality service and speed to clinical data. If you need a complete service including data management, data analysis, statistics and medical writing, Quotient is your answer.

Contact

Clinical PK/PD and Pharmacometrics Services

Clinical Trials >> Early Clinical / Phase I-IIa >> Pharmacokinetics / Pharmacodynamics / Pharmacometrics

PAREXEL’s global team of experienced clinical pharmacokineticists and pharmacometricians offer unsurpassed expertise in Clinical PK/PD and Pharmacometrics, from pre-clinical to Phase III studies.

Contact

Supporting Drug Development at Phase I & II

Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa

MPI Research is a full early-stage drug development CRO that partners with biopharmaceutical, biotechnology, medical device, animal health, and chemical industries to advance global healthcare. MPI Research supports all phases of the drug development pathway, ranging from target identification

Contact

Study Start-Up

Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa

Our team understands that upfront planning is critical for the success of every clinical trial and that planning must be produced in cooperation with your clinical team.

Contact

Clinical Development Services & Solutions

Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa

Chiltern provides the following services for Phase llb - III Late-stage programs: Protocol feasibility and design, CRF development, Recruitment, Data management, Medical writing, Biostatistics, Drug safety monitoring committees

Contact

Radiolabeled ADME Studies

Clinical Trials >> Early Clinical / Phase I-IIa >> Pharmacokinetics / Pharmacodynamics / Pharmacometrics

In response to a growing interest in conducting human 14C-radiolabeled ADME studies earlier in drug development, Celerion has expanded its ADME suite in Lincoln, Nebraska.

Contact

Early Development Clinical Research Services

Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa

Program services offered by both clinics range from medical writing, clinical conduct and data management to monitoring, biostatistics and clinical pharmacology.

Contact

14C-Radiolabeled Microtracer Studies

Clinical Trials >> Early Clinical / Phase I-IIa >> Pharmacokinetics / Pharmacodynamics / Pharmacometrics

Celerion’s clinic in Lincoln, Nebraska, is the only Phase I facility in North America with proven experience to release radiolabeled drug to regulatory standards that has been formulated on site for intravenous use in humans. This is required to perform assessments of absolute bioavailability

PharmaCompass >>

Filter By

Sub Category

Country

Companies See All